Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
347.40    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.80 (0.518%)
Market Cap: £2.54b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Director Declaration

16 Nov 2018 15:42

RNS Number : 6692H
TP ICAP PLC
16 November 2018
 

TP ICAP PLC

 

16 November 2018

 

TP ICAP plc confirms regulatory approval of Nicolas Breteau

 

Following the appointment of Nicolas Breteau as Chief Executive on 10 July 2018, TP ICAP plc (the "Company") is pleased to confirm that on 14 November 2018 it received regulatory approval from the Financial Conduct Authority of Mr Breteau's appointment as Executive Director (CF1) at Tullet Prebon (Securities) Limited, ICAP Securities Limited and iSwap Euro Limited.

 

There are no other details that are required to be disclosed in respect of Mr Breteau's appointment under Paragraph 9.6.13 of the Listing Rules of the UK Listing Authority.

 

ENDS

 

Media enquiries:

 

Jamie Dunkley

Jamie.Dunkley@tpicap.com

+44 (0) 20 7200 7524

 

About TPICAP

TP ICAP brings together buyers and sellers in global financial, energy and commodities markets. It is the world's largest wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world. We operate from offices in 31 countries, supporting award-winning brokers with market-leading technology.

www.tpicap.com

 

About Nicolas Breteau

Nicolas Breteau has extensive experience across the global broking industry. He joined Tullett Prebon as Chief Commercial Officer in 2016, and then moved to run TP ICAP's largest business, Global Broking.

Nicolas started his career in 1993 on the Listed Derivatives Exchange MATIF (later part of Euronext). From 1993 to 1998, he held several senior positions at the derivatives broker FIMAT, including Deputy CEO of the

Paris Office. He then moved to London as Head of Risk for EMEA, and subsequently became Deputy CEO then CEO of the FIMAT London Branch.

In 2005, Nicolas was promoted to CEO of EMEA, a position he consolidated after Newedge was formed through the merger of FIMAT with Calyon Financial in 2008. He was appointed Global Head of Sales and Front-Office in 2009 and became Chief Executive of Newedge Group in 2010. He moved from Newedge in 2014 following the sale of the company to Société Générale, and became Senior Managing Partner of a consulting firm, 99 Advisory.

Nicolas graduated from Ecole Superieure de Commerce de Bordeaux. He has been a director of several Boards including the Futures and Options Association (UK), Futures Industry Association (USA), Altura (Spain), Citic/Newedge (China) and has been the chairman of i-swap since February 2018.

He is a trustee at PSE For a Child's Smile UK, which helps deprived children in Cambodia.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNUNSVRWRAAAAA
Date   Source Headline
5th Jan 20172:13 pmRNSHolding(s) in Company
4th Jan 201711:38 amRNSHolding(s) in Company
3rd Jan 20175:51 pmRNSTotal Voting Rights
30th Dec 20168:05 amRNSAdmission of new shares
30th Dec 20167:00 amRNSCompletion of transaction with NEX
28th Dec 201611:07 amRNSChange of Name
28th Dec 20167:00 amRNSStatement re transaction with NEX
9th Dec 20167:00 amRNSDividend Declaration
6th Dec 20161:40 pmRNSStatement re transaction with ICAP
1st Dec 201610:02 amRNSHolding(s) in Company
23rd Nov 201611:29 amRNSHolding(s) in Company
15th Nov 201612:09 pmRNSStatement re transaction with ICAP
4th Nov 20167:00 amRNSTrading Statement
1st Nov 201612:52 pmRNSDirector Declaration
3rd Oct 20162:34 pmRNSTP ICAP Global Executive Committee
3rd Oct 20162:29 pmRNSTullett Prebon Management Changes
3rd Oct 20169:55 amRNSTotal Voting Rights
27th Sep 20162:15 pmRNSAdditional Listing
26th Sep 20167:03 amRNSStatement re transaction with ICAP
12th Sep 20163:49 pmRNSPublication of Supplementary Prospectus
8th Sep 201612:20 pmRNSStatement on transaction with Tullett Prebon
8th Sep 201612:15 pmRNSStatement re transaction with ICAP
24th Aug 20162:15 pmRNSHolding(s) in Company
3rd Aug 20162:15 pmRNSDirector/PDMR Shareholding
2nd Aug 20169:08 amRNSNew Technology Centre, Belfast Northern Ireland
2nd Aug 20167:00 amRNSHalf-year Report
22nd Jul 20161:15 pmRNSStatement re transaction with ICAP
29th Jun 20166:00 pmRNSNotification of Interim Results
21st Jun 20166:25 pmRNSStatement re transaction with ICAP
20th Jun 201610:21 amRNSHolding(s) in Company
7th Jun 20167:09 amRNSStatement re. CMA announcement
6th Jun 20164:18 pmRNSHolding(s) in Company
16th May 201612:08 pmRNSPublication of Supplementary Prospectus
16th May 20167:13 amRNSIGBB FY 2016 results
13th May 201612:16 pmRNSDirectorate Change
13th May 201610:17 amRNSResult of AGM
12th May 20167:00 amRNSTrading Statement
6th May 20167:00 amRNSDirectorate Change
5th May 20164:41 pmRNSDirector/PDMR Shareholding
4th May 201612:51 pmRNSHolding(s) in Company
22nd Apr 20165:18 pmRNSDirector/PDMR Shareholding
19th Apr 20165:27 pmRNSDirector/PDMR Shareholding
5th Apr 20162:49 pmRNSPublication of Supplementary Prospectus
4th Apr 20164:48 pmRNSAnnual Financial Report
24th Mar 20162:16 pmRNSEGM Statement
1st Mar 201611:37 amRNSPublication of Prospectus
1st Mar 20167:00 amRNSFinal Results
1st Mar 20167:00 amRNSStatement re acquisition
5th Feb 20168:00 amRNSAdoption of Financial Reporting Standard (FRS)101
2nd Feb 20167:00 amRNSStatement re acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.